Holen Sie sich die Stockscreener-App
39.96
2.94%
-1.21
Handel nachbörslich:
39.70
-0.26
-0.65%
Finanzdaten der Vera Therapeutics Inc-Aktie (VERA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
12.24%
94.21
|
83.93 | 80.14 | 57.19 | 48.91 |
| Operating Income/Loss |
12.24%
-94.21
|
-83.93 | -80.14 | -57.19 | -48.91 |
| Nonoperating Income/Loss |
14.54%
3.11
|
3.639 | 3.61 | 5.50 | 5.49 |
| Income/Loss From Continuing Operations Before Tax |
13.45%
-91.10
|
-80.29 | -76.53 | -51.69 | -43.42 |
| Income/Loss From Continuing Operations After Tax |
13.46%
-91.10
|
-80.29 | -76.53 | -51.69 | -43.42 |
|
Net Income/Loss
|
13.46%
-91.10
|
-80.29 | -76.53 | -51.69 | -43.42 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
99.27%
0.4639
|
63.85 | 63.79 | 63.67 | 1.7888 |
| Diluted Average Shares |
99.27%
0.4639
|
63.85 | 63.79 | 63.67 | 1.7888 |
| Basic Earnings Per Share |
10.32%
-1.39
|
-1.26 | -1.20 | -0.81 | -0.72 |
| Diluted Earnings Per Share |
10.32%
-1.39
|
-1.26 | -1.20 | -0.81 | -0.72 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):